Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria.
暂无分享,去创建一个
M. Ghannoum | B. Alexander | Steven D. Brown | M. Arendrup | T. Walsh | M. Pfaller | M. Motyl | D. Andes | D. Diekema | A. Espinel-Ingroff | Elizabeth M. Johnson | V. Chaturvedi | L. Ostrosky-Zeichner | C. Fowler | C. Knapp